Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20151219025600N5
IRCT20151219025600N5
Recruiting
Phase 3

Studying the bolus dose of Dexmedetomidine effect in attenuating hemodynamic stress response to laryngoscopy and tracheal intubation in hypertensive patients

Oroumia University of Medical Sciences0 sites70 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsArterial Blood Pressure.Hypertension (arterial)(benign)(essential)(malignant)(primary)(systemic)

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Arterial Blood Pressure.
Sponsor
Oroumia University of Medical Sciences
Enrollment
70
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Oroumia University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •normotensive Patients
  • •Stage I\-II hypertensive patients
  • •patients at age 40\-70

Exclusion Criteria

  • •Difficult intubation
  • •BMI more than 30
  • •Patient receiving Clonidine
  • •Laryngoscopy more than 20 seconds
  • •Emergency surgery
  • •Patients with heart blocks
  • •ASA class III and more
  • •Patients with pheochromocytoma
  • •Patients with thyroid disorders
  • •Patients with neuropathy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
To study the effect of bolus free dexmedetomidine infusionat minimal maintainence dose for hemodynamic stability & potentially blood less field intra operatively.Health Condition 1: O- Medical and Surgical
CTRI/2023/07/054851Bharati Vidyapeeth Deemed University Medical college and hospital
Recruiting
Phase 2
Evaluation of Dexmedetomidine effect on mentally-disabled adults, candidate for dental treatment under general aneasthesia
IRCT20190626044013N2Esfahan University of Medical Sciences50
Completed
Phase 3
Evaluating the Effect of Dexmedetomidine Infusion on Gene Expression of Inflammatory Cytokines & Lymphocyte T CD4 + Transcription Factors in Elective Abdominal Aortic Aneurysm Repair
IRCT20190121042444N1Shahid Beheshti University of Medical Sciences30
Recruiting
Phase 1
Drug therapy for improving the renal function after kidney transplantatioEnd-stage renal disease.Chronic kidney disease, stage 5
IRCT2017101331487N5Vice-chancellor for Research, Iran University of Medical Sciences50
Completed
Phase 2
The evaluation of the effect of dexmedetomidine added to local infiltration of bupivacaine on post-operative pain of pediatric inguinal herniorraphy.Inguinal hernia.Inguinal hernia
IRCT2016060314372N8Vice Chancellor for Research, Shiraz University of Medical Sciences60